117 related articles for article (PubMed ID: 23692186)
1. Physiological mechanisms for the increase in renal solute-free water clearance by a glucagon-like peptide-1 mimetic.
Kutina AV; Marina AS; Shakhmatova EI; Natochin YV
Clin Exp Pharmacol Physiol; 2013 Aug; 40(8):510-7. PubMed ID: 23692186
[TBL] [Abstract][Full Text] [Related]
2. Role of Vasopressin in the Regulation of Renal Sodium Excretion: Interaction with Glucagon-Like Peptide-1.
Kutina AV; Golosova DV; Marina AS; Shakhmatova EI; Natochin YV
J Neuroendocrinol; 2016 Apr; 28(4):. PubMed ID: 26791475
[TBL] [Abstract][Full Text] [Related]
3. Glucagon-like peptide-1 receptor stimulation increases GFR and suppresses proximal reabsorption in the rat.
Thomson SC; Kashkouli A; Singh P
Am J Physiol Renal Physiol; 2013 Jan; 304(2):F137-44. PubMed ID: 23019232
[TBL] [Abstract][Full Text] [Related]
4. Glucagon-like peptide-1 (GLP-1) receptor agonism or DPP-4 inhibition does not accelerate neoplasia in carcinogen treated mice.
Kissow H; Hartmann B; Holst JJ; Viby NE; Hansen LS; Rosenkilde MM; Hare KJ; Poulsen SS
Regul Pept; 2012 Nov; 179(1-3):91-100. PubMed ID: 22989472
[TBL] [Abstract][Full Text] [Related]
5. Involvement of Glucagon-Like Peptide-1 in the Regulation of Selective Excretion of Sodium or Chloride Ions by the Kidneys.
Marina AS; Kutina AV; Shakhmatoba EI; Natochin YV
Bull Exp Biol Med; 2017 Feb; 162(4):436-440. PubMed ID: 28243920
[TBL] [Abstract][Full Text] [Related]
6. Biological activity of AC3174, a peptide analog of exendin-4.
Hargrove DM; Kendall ES; Reynolds JM; Lwin AN; Herich JP; Smith PA; Gedulin BR; Flanagan SD; Jodka CM; Hoyt JA; McCowen KM; Parkes DG; Anderson CM
Regul Pept; 2007 Jun; 141(1-3):113-9. PubMed ID: 17292977
[TBL] [Abstract][Full Text] [Related]
7. Redistribution of Proximal and Distal Reabsorption of Water and Ions in Rat Kidney After Treatment with Glucagon-Like Peptide-1 Mimetic.
Natochin YV; Marina AS; Kutina AV
Bull Exp Biol Med; 2015 Nov; 160(1):9-12. PubMed ID: 26601838
[TBL] [Abstract][Full Text] [Related]
8. The mechanism of glucagon-like peptide-1 participation in the osmotic homeostasis.
Natochin YV; Marina AS; Kutina AV; Balbotkina EV; Karavashkina TA
Dokl Biol Sci; 2016 Jul; 469(1):156-8. PubMed ID: 27595820
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms mediating the diuretic and natriuretic actions of the incretin hormone glucagon-like peptide-1.
Crajoinas RO; Oricchio FT; Pessoa TD; Pacheco BP; Lessa LM; Malnic G; Girardi AC
Am J Physiol Renal Physiol; 2011 Aug; 301(2):F355-63. PubMed ID: 21593184
[TBL] [Abstract][Full Text] [Related]
10. [DIFFERENCES OF EXENATIDE EFFECTS ON GLYCEMIA AND RENAL WATER AND ION EXCRETION IN FROGS AND RATS].
Kutina AV; Marina AS; Natochin YV
Zh Evol Biokhim Fiziol; 2016 Mar; 52(2):205-213. PubMed ID: 30695500
[TBL] [Abstract][Full Text] [Related]
11. Glucagon-like peptide 1 receptor expression in primary porcine proximal tubular cells.
Schlatter P; Beglinger C; Drewe J; Gutmann H
Regul Pept; 2007 Jun; 141(1-3):120-8. PubMed ID: 17276524
[TBL] [Abstract][Full Text] [Related]
12. Renal hemodynamic effects of glucagon-like peptide-1 agonist are mediated by nitric oxide but not prostaglandin.
Thomson SC; Kashkouli A; Liu ZZ; Singh P
Am J Physiol Renal Physiol; 2017 Oct; 313(4):F854-F858. PubMed ID: 28724607
[TBL] [Abstract][Full Text] [Related]
13. Activation of GLP-1 receptors on vascular smooth muscle cells reduces the autoregulatory response in afferent arterioles and increases renal blood flow.
Jensen EP; Poulsen SS; Kissow H; Holstein-Rathlou NH; Deacon CF; Jensen BL; Holst JJ; Sorensen CM
Am J Physiol Renal Physiol; 2015 Apr; 308(8):F867-77. PubMed ID: 25656368
[TBL] [Abstract][Full Text] [Related]
14. [Incretin role in osmotic homeostasis in rats].
Marina AS; Kutina AV; Natochin IuV
Ross Fiziol Zh Im I M Sechenova; 2012 Nov; 98(11):1362-71. PubMed ID: 23431766
[TBL] [Abstract][Full Text] [Related]
15. Peptidic exenatide and herbal catalpol mediate neuroprotection via the hippocampal GLP-1 receptor/β-endorphin pathway.
Jia Y; Gong N; Li TF; Zhu B; Wang YX
Pharmacol Res; 2015 Dec; 102():276-85. PubMed ID: 26546042
[TBL] [Abstract][Full Text] [Related]
16. [EFFECTS OF ORALLY AND PARENTERALLY ADMINISTERED ANALOGS OF PEPTIDE HORMONES ON RENAL WATER AND ION TRANSPORT].
Kutina AV; Golosova DV; Marina AS; Karavashkina TA; Natochin YV
Ross Fiziol Zh Im I M Sechenova; 2016 Oct; 102(10):1185-94. PubMed ID: 30193436
[TBL] [Abstract][Full Text] [Related]
17. Effects of the glucagon-like peptide-1 (GLP-1) analogues exenatide, exenatide extended-release, and of the dipeptidylpeptidase-4 (DPP-4) inhibitor sitagliptin on glucose metabolism in healthy cats.
Padrutt I; Lutz TA; Reusch CE; Zini E
Res Vet Sci; 2015 Apr; 99():23-9. PubMed ID: 25648286
[TBL] [Abstract][Full Text] [Related]
18. Glucagon-like peptide-1 receptor activation stimulates hepatic lipid oxidation and restores hepatic signalling alteration induced by a high-fat diet in nonalcoholic steatohepatitis.
Svegliati-Baroni G; Saccomanno S; Rychlicki C; Agostinelli L; De Minicis S; Candelaresi C; Faraci G; Pacetti D; Vivarelli M; Nicolini D; Garelli P; Casini A; Manco M; Mingrone G; Risaliti A; Frega GN; Benedetti A; Gastaldelli A
Liver Int; 2011 Oct; 31(9):1285-97. PubMed ID: 21745271
[TBL] [Abstract][Full Text] [Related]
19. GLP-1 receptor agonists have a sustained stimulatory effect on corticosterone release after chronic treatment.
Krass M; Volke A; Rünkorg K; Wegener G; Lund S; Abildgaard A; Vasar E; Volke V
Acta Neuropsychiatr; 2015 Feb; 27(1):25-32. PubMed ID: 25469828
[TBL] [Abstract][Full Text] [Related]
20. Discovery and development of exenatide: the first antidiabetic agent to leverage the multiple benefits of the incretin hormone, GLP-1.
Parkes DG; Mace KF; Trautmann ME
Expert Opin Drug Discov; 2013 Feb; 8(2):219-44. PubMed ID: 23231438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
